Overview of patients included in the analysis by risk classification, HLA typing, and donor availability. AML indicates acute myeloid leukemia; CR, complete remission; HSCT, hematopoietic stem-cell transplantation. HRD, haploidentical related donor; MSD, matched sibling donor; and MUD, matched unrelated donor.